scholarly article | Q13442814 |
P50 | author | Yong Fan | Q85343782 |
P2093 | author name string | Yan Chen | |
Wei Zhu | |||
Jin Li | |||
Lian-Wen Qi | |||
Xin Zhou | |||
Qun Liu | |||
Ping Li | |||
Zhuo Chen | |||
Tian-Song Xia | |||
Mao-De Lai | |||
Raphael N Alolga | |||
P2860 | cites work | Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression | Q24654019 |
Cancer statistics, 2015 | Q27860576 | ||
On the Origin of Cancer Cells | Q27861025 | ||
Molecular portraits of human breast tumours | Q28032461 | ||
Repeated observation of breast tumor subtypes in independent gene expression data sets | Q28131820 | ||
The clonal and mutational evolution spectrum of primary triple-negative breast cancers | Q29619914 | ||
Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA | Q29620083 | ||
Cytosolic phospholipase A2 activation correlates with HER2 overexpression and mediates estrogen-dependent breast cancer cell growth. | Q30352693 | ||
Diagnosis of bladder cancer and prediction of survival by urinary metabolomics | Q33688951 | ||
Frequent amplification of ORAOV1 gene in esophageal squamous cell cancer promotes an aggressive phenotype via proline metabolism and ROS production. | Q33917534 | ||
Metabonomics: a platform for studying drug toxicity and gene function | Q34139125 | ||
Cytosolic phospholipase A2-α expression in breast cancer is associated with EGFR expression and correlates with an adverse prognosis in luminal tumours. | Q34543740 | ||
The functional characterization of long noncoding RNA SPRY4-IT1 in human melanoma cells | Q34619182 | ||
Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and Alzheimer's disease using metabolomics. | Q34735142 | ||
Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma | Q35098539 | ||
Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis | Q35234332 | ||
Personalized medicine in a phase I clinical trials program: the MD Anderson Cancer Center initiative | Q35680026 | ||
Cellular fatty acid metabolism and cancer | Q37092913 | ||
Use of high-resolution proton nuclear magnetic resonance spectroscopy for rapid multi-component analysis of urine | Q42246794 | ||
Breast cancer subtypes and the risk of local and regional relapse. | Q42468027 | ||
Breast cancer molecular subtypes respond differently to preoperative chemotherapy | Q42482998 | ||
Metabolic characterization of hepatocellular carcinoma using nontargeted tissue metabolomics | Q44819530 | ||
Comparative metabolomics of estrogen receptor positive and estrogen receptor negative breast cancer: alterations in glutamine and beta-alanine metabolism | Q46743426 | ||
Glutamate enrichment as new diagnostic opportunity in breast cancer. | Q52874359 | ||
Urine Metabolite Analysis Offers Potential Early Diagnosis of Ovarian and Breast Cancers | Q85214889 | ||
P4510 | describes a project that uses | Cytoscape | Q3699942 |
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | metabolomics | Q12149006 |
P304 | page(s) | 9925-9938 | |
P577 | publication date | 2016-03-01 | |
P1433 | published in | Oncotarget | Q1573155 |
P1476 | title | Human plasma metabolomics for identifying differential metabolites and predicting molecular subtypes of breast cancer | |
P478 | volume | 7 |
Q90192592 | A High-Performing Plasma Metabolite Panel for Early-Stage Lung Cancer Detection |
Q37699460 | A characteristic biosignature for discrimination of gastric cancer from healthy population by high throughput GC-MS analysis |
Q37746050 | A plasma metabolomic signature discloses human breast cancer. |
Q64096210 | Akebia Saponin D Regulates the Metabolome and Intestinal Microbiota in High Fat Diet-Induced Hyperlipidemic Rats |
Q90577002 | Application of metabolomics in the diagnosis of breast cancer: a systematic review |
Q64923534 | Breast Cancer Metabolomics: From Analytical Platforms to Multivariate Data Analysis. A Review. |
Q101561965 | Cancer Alters the Metabolic Fingerprint of Extracellular Vesicles |
Q37687130 | Comparative metabolic and lipidomic profiling of human breast cancer cells with different metastatic potentials |
Q64076197 | Current Status and Future Prospects of Clinically Exploiting Cancer-specific Metabolism-Why Is Tumor Metabolism Not More Extensively Translated into Clinical Targets and Biomarkers? |
Q47836759 | Deciphering metabolic rewiring in breast cancer subtypes |
Q45944093 | Deep Learning Accurately Predicts Estrogen Receptor Status in Breast Cancer Metabolomics Data. |
Q89511033 | Effect of Estrogen Receptor Status on Circulatory Immune and Metabolomics Profiles of HER2-Positive Breast Cancer Patients Enrolled for Neoadjuvant Targeted Chemotherapy |
Q48200976 | High-throughput extraction and quantification method for targeted metabolomics in murine tissues. |
Q91670973 | Leveraging User-Friendly Network Approaches to Extract Knowledge From High-Throughput Omics Datasets |
Q91901506 | Metabolite profiling in sphere-forming cells from canine mammary adenocarcinoma cell lines using gas chromatography-mass spectrometry |
Q49511137 | Metabolomic alterations in invasive ductal carcinoma of breast: A comprehensive metabolomic study using tissue and serum samples. |
Q37427026 | Metabolomic profiling of breast tumors using ductal fluid. |
Q38689857 | Metabolomics applications in precision medicine: An oncological perspective |
Q55518177 | Metabolomics research on potential role for 9-cis-retinoic acid in breast cancer progression. |
Q50041769 | Multiplatform plasma metabolic and lipid fingerprinting of breast cancer: A pilot control-case study in Colombian Hispanic women |
Q88409664 | NMR-based metabolomics of biofluids in cancer |
Q60926108 | Plasma mitochondrial DNA and metabolomic alterations in severe critical illness |
Q55265458 | Robust volcano plot: identification of differential metabolites in the presence of outliers. |
Q52714844 | The Effects of Graded Levels of Calorie Restriction: XIII. Global Metabolomics Screen Reveals Graded Changes in Circulating Amino Acids, Vitamins, and Bile Acids in the Plasma of C57BL/6 Mice. |
Search more.